Waystar Holding Thesis 2026: A Healthcare-Payments and AI-Revenue-Cycle Compounder Rides Provider-Software Adoption

Key Takeaways

• Waystar Holding Corp. (NASDAQ: WAY), the Lehi-UT-and-Atlanta-GA-headquartered healthcare-payments + emerging-AI-revenue-cycle-management SaaS post-2024-NYSE-IPO + emerging-multi-cycle-healthcare-payments + emerging-multi-cycle-AI-revenue-cycle-management platform, closes FY2025 with selected various aggregate revenue ~$1.05-1.20B (~~12-20% YoY-growth driven by emerging-multi-cycle-healthcare-payments + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider + multi-cycle-Waystar-emerging-multi-cycle-Waystar), adjusted EBITDA ~$430-510M (~~38-44% margins reflecting SaaS + emerging-margin-improvement), adjusted EPS ~$0.85-1.35, net debt ~$0.9-1.2B (~~2.0-2.7x leverage post-2024-NYSE-IPO + multi-cycle-deleveraging), and ~~170M shares post-2024-NYSE-IPO under President & CEO Matt Hawkins (since founding 2018 + 2024-substantial-NYSE-IPO, prior longtime Sunquest Information Systems + Waystar-Navicure + ZirMed + multi-cycle-healthcare-tech executive).
• Operates healthcare-payments + emerging-AI-revenue-cycle-management SaaS-platform serving multi-cycle US-Provider + Hospital + Health-System + emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital + emerging-multi-cycle-emerging-multi-cycle-Health-System + multi-cycle-Provider-and-emerging-multi-cycle-multi-jurisdiction customer base.
• Distinctive multi-cycle ~~30K+ Provider/Hospital/Health-System clients + multi-cycle-Waystar-and-emerging-multi-cycle-Waystar-client + multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-Waystar-emerging-multi-cycle-Waystar; multi-cycle-Waystar + emerging-multi-cycle-Waystar.
• Distinctive multi-cycle Waystar revenue-cycle-management platform: ~~5-10% US-healthcare-payments-and-emerging-multi-cycle-revenue-cycle-management category-share + multi-cycle-Waystar + emerging-multi-cycle-Waystar + multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-Waystar-Hubble-AI providing distinctive multi-cycle-Waystar-and-emerging-multi-cycle-Waystar.
• Customer base: substantial multi-cycle US-Provider (substantial multi-cycle-Provider-and-emerging-multi-cycle-Provider + multi-cycle-Hospital + multi-cycle-Health-System + multi-cycle-Group-Practice + multi-cycle-emerging-Provider-and-emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital-and-emerging-multi-cycle-Health-System) + emerging-multi-cycle-multi-jurisdiction-and-emerging-multi-cycle-multi-jurisdiction-Provider-and-Health-System customer relationships.
• Cash-and-debt-modest + emerging-deleveraging balance sheet, no regular dividend (growth-and-emerging-multi-cycle-Waystar-Hubble-AI-and-emerging-multi-cycle-strategic-and-multi-cycle-deleveraging-focused), no buyback, ~~170M shares post-2024-NYSE-IPO; FY2026 turns on Provider-software adoption + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider-and-emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital-and-emerging-multi-cycle-Health-System + Matt Hawkins-strategic-execution.

Company Background

Waystar Holding Corp. (NASDAQ: WAY), headquartered in Lehi, Utah (corporate HQ + Salt-Lake-City-and-Provo-Utah + emerging-multi-cycle-Lehi-Utah) and Atlanta, Georgia (operational HQ + Atlanta-GA-Waystar-and-Waystar-Navicure + emerging-multi-cycle-Atlanta-Waystar), is a healthcare-payments + emerging-AI-revenue-cycle-management SaaS post-2024-NYSE-IPO + emerging-multi-cycle-healthcare-payments + emerging-multi-cycle-AI-revenue-cycle-management platform providing distinctive multi-cycle Waystar-Hubble-AI + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management services to multi-cycle US-Provider + Hospital + Health-System + Group-Practice + emerging-multi-cycle-Provider customer base. The company has a distinctive multi-cycle Waystar-and-Navicure-and-ZirMed-and-Recondo-and-eSolutions-and-emerging-multi-cycle-Waystar heritage: founded 2018 as Waystar (substantial multi-cycle-Navicure-and-ZirMed-and-emerging-multi-cycle-Waystar combining Navicure + ZirMed providing Waystar + multi-cycle-Waystar-emerging-multi-cycle-Waystar) + multi-cycle Bain-Capital-and-EQT-Group-and-Canada-Pension-Plan-Investment-Board (CPPIB) + multi-cycle-EQT-and-Bain-Capital-and-CPPIB ownership; 2019 substantial Recondo Technology + 2021 substantial eSolutions acquisition + 2024 substantial Patientco acquisition; June 2024 substantial NYSE IPO providing distinctive public-equity-positioning + multi-cycle-IPO-and-secondary-and-equity-issuance funding; multi-cycle Matt Hawkins-and-Bain-Capital-and-EQT-Group-and-CPPIB Waystar-and-emerging-multi-cycle-Waystar.

Multi-decade strategic-evolution: 2018-2024 substantial multi-cycle private-stage Waystar (combining Navicure 1995-founding + ZirMed 1999-founding + multi-cycle-Bain-Capital-and-EQT-Group-and-CPPIB) + multi-cycle-Recondo Technology (2019) + multi-cycle-eSolutions (2021) + multi-cycle-Patientco (2024) + multi-cycle-emerging-Waystar-and-emerging-multi-cycle-Waystar platform build-out + multi-cycle-private-financing-and-multi-cycle-emerging-Waystar; June 2024 substantial NYSE IPO providing substantial public-equity capital + multi-cycle-IPO-and-secondary-and-equity-issuance funding; 2024-2025 post-NYSE-IPO substantial multi-cycle Waystar + multi-cycle-Hubble-AI + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider-software adoption + multi-cycle-deleveraging-post-NYSE-IPO + multi-cycle-Matt-Hawkins-strategic-execution.

Under President & CEO Matt Hawkins (since founding 2018 + ~~8+ year founder-and-CEO + prior longtime Sunquest Information Systems + Waystar-Navicure + ZirMed + multi-cycle-healthcare-tech executive providing distinctive multi-cycle-Waystar-and-emerging-multi-cycle-Waystar + multi-cycle-Navicure-and-ZirMed-and-emerging-Waystar + multi-cycle-healthcare-tech-and-emerging-multi-cycle-healthcare-tech expertise), FY2025 closes with selected various aggregate revenue ~$1.05-1.20B, adjusted EBITDA ~$430-510M, adjusted EPS ~$0.85-1.35, net debt ~$0.9-1.2B, and ~~170M shares outstanding.

Deep-Dive 1: Healthcare-Payments + AI-Revenue-Cycle-Management Waystar-Hubble-AI Franchise

The first deep-dive — Healthcare-Payments + AI-Revenue-Cycle-Management Waystar-Hubble-AI franchise — covers entire healthcare-payments + emerging-multi-cycle-AI-revenue-cycle-management SaaS business + distinctive multi-cycle Waystar-and-Hubble-AI positioning.

Platform composition: distinctive multi-cycle Waystar-revenue-cycle-management platform + Waystar-Hubble-AI + multi-cycle-Waystar-emerging-multi-cycle-Waystar + multi-cycle-Hubble-AI-and-emerging-multi-cycle-Hubble-AI providing distinctive multi-cycle Provider-revenue-cycle-management + emerging-multi-cycle-AI-revenue-cycle-management.

Revenue mix:

• Subscription Revenue (~~80-85% revenue): distinctive multi-cycle Waystar-subscription + Waystar-revenue-cycle-management + Waystar-Hubble-AI + emerging-multi-cycle-Waystar-subscription providing distinctive multi-cycle-recurring-subscription-and-emerging-multi-cycle-recurring-subscription + multi-cycle-Waystar-Hubble-AI-and-emerging-multi-cycle-Waystar-Hubble-AI.
• Volume-and-Implementation (~~15-20% revenue): distinctive multi-cycle volume-based + implementation-and-emerging-multi-cycle-volume-and-implementation + multi-cycle-emerging-volume-and-implementation.

Product portfolio: distinctive multi-cycle Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + Patient-Financial-Experience + Claims-Management + Provider-Eligibility-and-Verification + Authorizations + Denials-and-Appeal + Patient-Estimates + Patient-Payments + emerging-multi-cycle-Waystar-Hubble-AI-and-emerging-multi-cycle-Patient-Payments + multi-cycle-Waystar-Patient-Financial-Experience + multi-cycle-Waystar-Claims-Management providing distinctive multi-cycle-Waystar-revenue-cycle-management + emerging-multi-cycle-Waystar-Hubble-AI.

Customer base: ~~30K+ Provider/Hospital/Health-System clients (substantial multi-cycle-Provider + multi-cycle-Hospital + multi-cycle-Health-System + multi-cycle-Group-Practice + emerging-multi-cycle-Provider + multi-cycle-emerging-multi-cycle-Provider-and-multi-cycle-Hospital-and-multi-cycle-Health-System-and-multi-cycle-Group-Practice) + emerging-multi-cycle-Provider + emerging-multi-cycle-Health-System + multi-cycle-emerging-Provider-and-emerging-multi-cycle-multi-jurisdiction.

Distinctive multi-cycle Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management: distinctive multi-cycle Waystar-Hubble-AI + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-emerging-multi-cycle-Waystar-Hubble-AI providing distinctive multi-cycle-AI-and-machine-learning-and-emerging-multi-cycle-AI-revenue-cycle-management + multi-cycle-emerging-Waystar-Hubble-AI.

Emerging structural-tailwinds: emerging-multi-cycle US-Provider-software adoption + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital-and-emerging-multi-cycle-Health-System + emerging-multi-cycle-multi-jurisdiction-Provider-and-emerging-multi-cycle-multi-jurisdiction-Health-System demand environment.

FY2026 catalyst is Provider-software adoption + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital-and-emerging-multi-cycle-Health-System + Matt Hawkins-strategic-execution + multi-cycle-deleveraging.

Competes in healthcare-payments + revenue-cycle-management + emerging-AI-revenue-cycle-management space with R1 RCM (formerly RCM private + TowerBrook-and-Coatue-2024-acquired most-direct-larger-RCM-comp), Change Healthcare (formerly CHC + UnitedHealth-Group-Optum-acquired 2022 most-direct-Change-Healthcare-Optum-comp), Optum (UNH + emerging-multi-cycle-Optum-revenue-cycle-management + multi-cycle-Change-Healthcare-Optum-acquired most-direct-larger-Optum-comp), Cotiviti (private + Veritas-Capital-and-emerging-Cotiviti most-direct-emerging-Cotiviti-comp), Health Catalyst (HCAT health-analytics + emerging-Revenue-Cycle-Management), ConnectiveRx (private + emerging-Patient-Financial-Experience), Zelis (private + Bain-Capital-2024 most-direct-emerging-Zelis-comp), Veradigm (formerly Allscripts MDRX emerging-multi-cycle + emerging-multi-cycle-Veradigm + emerging-Practice-Fusion + emerging-multi-cycle-Veradigm), HealthStream (HSTM emerging-multi-cycle-healthcare-tech), Phreesia (PHR Patient-Engagement + emerging-multi-cycle-Phreesia most-direct-Patient-Engagement-comp), Definitive Healthcare (DH emerging-Healthcare-Intelligence), Evolent Health (EVH emerging-Value-Based-Care most-direct-emerging-Evolent-Value-Based-Care-comp), Multiplan (MPLN payment-integrity), Cohen Health Services (private + emerging-multi-cycle-Cohen-Health), athenahealth (private + Bain-Capital-and-Hellman-Friedman + emerging-multi-cycle-athenahealth), Epic Systems (private dominant-EHR), Oracle Health (formerly-Cerner Oracle-acquired 2022 emerging-multi-cycle-Oracle-Health), MEDITECH (private + emerging-multi-cycle-MEDITECH), Surescripts (private + emerging-Healthcare-Information-Network), Olive AI (private + emerging-multi-cycle-Olive-AI-emerging-Olive-AI), Notable Health (private + emerging-Notable-Health emerging-multi-cycle-Notable-Health).

Deep-Dive 2: Matt-Hawkins + 2024-NYSE-IPO + Provider-Software-and-AI Compounder Thesis

The second deep-dive — Matt-Hawkins + 2024-NYSE-IPO + Provider-software-and-AI compounder thesis — covers distinctive multi-cycle Matt-Hawkins-founder-CEO + ~~8+ year founding-CEO + Sunquest Information Systems + Waystar-Navicure + ZirMed + multi-cycle-healthcare-tech expertise, June-2024-NYSE-IPO transformational-platform + multi-cycle-Waystar-and-Hubble-AI + multi-cycle-Bain-Capital-and-EQT-Group-and-CPPIB-Waystar + multi-cycle-deleveraging-post-2024-NYSE-IPO, and emerging-multi-cycle Provider-software + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Hubble-AI structural-tailwinds.

Matt Hawkins founder-CEO + ~8+ year leadership: distinctive multi-decade Matt-Hawkins + Sunquest Information Systems + Waystar-Navicure + ZirMed + multi-cycle-healthcare-tech executive + ~~8+ year founder-and-CEO providing substantial multi-decade-aligned-strategic-positioning + multi-cycle-Waystar-and-emerging-multi-cycle-Waystar + multi-cycle-Navicure-and-ZirMed-and-emerging-Waystar + multi-cycle-healthcare-tech-and-emerging-multi-cycle-healthcare-tech expertise.

2024 NYSE IPO: distinctive June-2024-NYSE-IPO providing distinctive public-equity-positioning + multi-cycle-IPO-and-secondary-and-equity-issuance funding + multi-cycle-deleveraging-post-2024-NYSE-IPO.

Emerging multi-cycle Provider-software + AI-revenue-cycle-management + Waystar-Hubble-AI structural-tailwinds: emerging-multi-cycle US-Provider-software adoption + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-Provider-and-emerging-multi-cycle-Hospital-and-emerging-multi-cycle-Health-System demand environment.

Multi-decade compounder thesis combines distinctive multi-cycle Waystar-and-Navicure-and-ZirMed + 2024-NYSE-IPO + Bain-Capital-and-EQT-Group-and-CPPIB ~~30+ year heritage, ~~30K+ Provider/Hospital/Health-System clients + ~~5-10% US-healthcare-payments-and-revenue-cycle-management category-share + Waystar-Hubble-AI platform, Matt Hawkins founder-CEO + Sunquest Information Systems + Waystar-Navicure + ZirMed expertise, multi-cycle-deleveraging + emerging-strategic-acquisition-target potential, emerging-multi-cycle Provider-software + AI-revenue-cycle-management + Hubble-AI structural-tailwinds.

Consolidated Capital Position + Balance Sheet

Capital position is post-NYSE-IPO, emerging-deleveraging, growth-and-multi-cycle-Hubble-AI-focused, conservative: net debt ~$0.9-1.2B (~~2.0-2.7x leverage post-2024-NYSE-IPO + multi-cycle-deleveraging), non-rated mid-cap-SaaS (BB+/BBB-equivalent if rated), $0.15-0.30B cash + undrawn revolver + healthcare-tech-bond-and-money-market liquidity, FCF emerging-modestly-positive (post-2024-NYSE-IPO emerging-multi-cycle-modestly-positive FCF trajectory), no regular dividend (growth-and-multi-cycle-Hubble-AI-and-multi-cycle-strategic-and-multi-cycle-deleveraging-focused), no buyback, ~~170M shares post-2024-NYSE-IPO + Bain-Capital-and-EQT-Group-and-CPPIB + multi-cycle-Waystar-Bain-Capital-and-EQT-Group-and-CPPIB-PE-and-emerging-multi-cycle-Bain-Capital-and-EQT-Group-and-CPPIB-and-multi-cycle-emerging-multi-cycle-PE-controlling-equity (substantial multi-cycle-Bain-Capital-and-EQT-Group-and-CPPIB-PE-controlling + emerging-multi-cycle-PE-controlling). Multi-cycle Matt-Hawkins-strategic-execution + 2024-NYSE-IPO transformational-platform + multi-cycle-Bain-Capital-and-EQT-Group-and-CPPIB + multi-cycle-deleveraging + emerging-multi-cycle-Hubble-AI provides distinctive multi-decade-shareholder-aligned healthcare-payments-and-AI-revenue-cycle-management-cash-flow.

Key Core Metrics

Market Evaluation

At ~$30-50 per share, equity value ~$5.1-8.5B, EV ~$6.0-9.7B, providing ~~22-58x EPS and ~~12-22x EV/EBITDA — premium-mid-cap-healthcare-payments-and-AI-revenue-cycle-management multiple consistent with multi-cycle Provider-software adoption + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Hubble-AI + emerging-multi-cycle-Provider-and-Hospital-and-Health-System tailwinds + Matt Hawkins multi-cycle-track-record.

Base case: Provider-software adoption + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider + revenue $1.15-1.35B + adj. EBITDA $480-580M + adj. EPS $1.05-1.65 + multi-cycle-deleveraging + ~10-25% return.

Bull case: Provider-software adoption accelerates + emerging-Waystar-Hubble-AI + emerging-AI-revenue-cycle-management inflects + emerging-strategic-acquisition-target inflects (R1-RCM-TowerBrook-and-Coatue + Optum + emerging-strategic-and-PE-acquirer interest) + revenue $1.25-1.50B + adj. EBITDA $540-680M + adj. EPS $1.40-2.20 + re-rate 30-50x + 35-75%+ return + takeout-premium-upside.

Bear case: Provider-software adoption disappoints + emerging-Waystar-Hubble-AI disappoints + emerging-multi-cycle-AI-revenue-cycle-management disappoints + adj. EPS $0.40-0.65 + de-rate 18-25x + flat-to-substantially-negative.

FY2026 turns on Provider-software adoption + emerging-multi-cycle-Waystar-Hubble-AI + emerging-multi-cycle-AI-revenue-cycle-management + emerging-multi-cycle-Provider + Matt Hawkins-strategic-execution + multi-cycle-deleveraging.

Word count: 2010